Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial
Further Publications Urology
Related content
Further Publications Urology
Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study
Lancet
Ross JDC, Wilson J, Workowski KA, Taylor SN, Lewis DA, Gatsi S, Flight W, Scangarella-Oman NE, Jakielaszek C, Lythgoe D, Powell M, Janmohamed S, Absalon J, Perry C
doi: 10.1016/S0140-6736(25)00628-2
Further Publications Gynecology
Prospective 1-year assessment of within-woman variability of follicular and luteal phase lengths in healthy women prescreened to have normal menstrual cycle and luteal phase lengths
Hum Reprod
Henry S, Shirin S, Goshtasebi A, Prior JC
doi: 10.1093/humrep/deae215
COMMENTED
Erectile and Sexual Functions and Dysfunctions
Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
J Clin Endocrinol Metab
Wittert GA, Robledo KP, Handelsman DJ, Inder WJ, Stuckey BGA, Yeap BB, Bracken K, Allan CA, Jesudason D, Jenkins A, Januszewski AS, Grossmann M
doi: 10.1210/clinem/dgaf060
Overactive BladderUrinary Incontinence
Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial
J Urol
Enemchukwu EA, Kalota S, Robertson K, Ge S, Lu J, Badger H, Mujais S, Peters KM
doi: 10.1097/JU.0000000000004373
Further Publications Urology
Long-Term Outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Coated Balloon: 5-year Results From the ROBUST I Study
J Urol
DeLong J, Virasoro R, Pichardo M, Estrella R, Rodríguez Lay R, Espino G, Elliott S
doi: 10.1097/JU.0000000000004229
Menopause
Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies
Adv Ther
Kagan R, Cano A, Nappi RE, English ML, Mancuso S, Wu X, Ottery FD
doi: 10.1007/s12325-024-03073-8
Benign Prostatic Hyperplasia (BPH)
Short term results after minimally invasive treatments for benign prostatic enlargement: the first randomized trial comparing transperineal laser ablation and water vapor ablation
Prostate Cancer Prostatic Dis
Pacini M, Zucchi A, Salonia A, Sollazzi E, Macrì G, Volterrani R, Bini V, Antonov P, Ivanov A, d'Arma A, De Nunzio C, Bartoletti R
doi: 10.1038/s41391-025-00972-x
Endometriosis
Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: 12 months of an ongoing randomized phase 3 trial
Am J Obstet Gynecol
Miller CE, Kim JH, Kroll R, Simon JA, Soliman AM, Thomas JW, Xu Y, Ng J, Snabes MC
doi: 10.1016/j.ajog.2024.06.040
Erectile and Sexual Functions and Dysfunctions
Comparison of the effectiveness of 2 shockwave therapy protocols for the treatment of vascular erectile dysfunction: a randomized, multicenter, open-label, noninferiority, phase 4 clinical trial
J Sex Med
Corredor HA, Sandoval-Salinas C, Martinez JM, Barba J, Patrón F
doi: 10.1093/jsxmed/qdae205